biote Corp Stock Pattern Recognition Advance Block
| BTMD Stock | USD 1.40 -0.14 -9.09% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of forty-nine. The function did not return any valid pattern recognition events for the selected time horizon. The Advance Block describes upcoming bearish signal for Biote Corp.
Biote Corp Technical Analysis Modules
Most technical analysis of Biote Corp help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biote from various momentum indicators to cycle indicators. When you analyze Biote charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
biote Corp is scheduled to announce its earnings this week.biote Corp. operates in medical practice-building business within the hormone optimization space. The company was founded in 2011 and is headquartered in Irvine, Texas. Biote Corp operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. Market structure and macro sensitivity help explain how Biote Corp behaves across regimes. Some cyclical sensitivity may emerge during periods of macroeconomic volatility. Biote Corp has a market cap of 66.99 M, P/E of 0.26.
Methodology
Unless otherwise specified, financial data for biote Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Biote (USA Stocks:BTMD) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report is built using public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Normalization for analytical consistency may introduce small timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
biote Corp may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardBecome your own money manager
Tracking Biote Corp inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Corona Opportunity Invested few shares | |
 | Baby Boomer Prospects Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Driverless Cars Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Advertising Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Software Invested few shares | |
 | Impulse Invested over 200 shares | |
 | Hedge Favorites Invested few shares | |
 | Warren Buffett Holdings Invested over 20 shares | |
 | Disruptive Technologies Invested few shares |
More Resources for Biote Stock Analysis
A comprehensive view of biote Corp starts with financial statements and ratio context. Ratio context helps frame profitability, efficiency, and growth trends for biote Corp Stock. Selected reports below provide context for Biote Stock:Biote Corp has a market cap of 66.99 M, operating margin of 14.72%. Review Trending Equities for broader portfolio context. This reflects a position in biote Corp within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Before investing in Biote Stock, review our How to Buy Biote Corp guide for key considerations.Analysis related to Biote Corp should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Quarterly Earnings Growth -0.40 | Earnings Share 0.79 | Revenue Per Share | Quarterly Revenue Growth -0.07 | Return On Assets |
Understanding biote Corp includes distinguishing between market value and book value, where book value reflects Biote's accounting equity. Biote Corp's market capitalization is 66.99 M. A P/B ratio of 2.96 indicates the market values Biote Corp above its accounting book value. Enterprise value stands at 121.26 M. Intrinsic value reflects what Biote Corp's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
It is useful to distinguish Biote Corp's value from its trading price, which are computed with different methods. For Biote Corp, key inputs include a P/E ratio of 0.26, a P/B ratio of 2.96, a profit margin of 14.07%, and revenue of 192.22 M. The quoted price is simply the exchange level where supply meets demand.